Enhancing validity in co-occurring disorders treatment research. - Wikidata - awgldk - TriplyDB

Enhancing validity in co-occurring disorders treatment research.

Enhancing validity in co-occurring disorders treatment research.

http://www.wikidata.org/entity/Q36540048

about

Substance use outcomes among homeless clients with serious mental illness: comparing Housing First with Treatment First programs Management of persons with co-occurring severe mental illness and substance use disorder: program implications.Psychiatric Comorbidity in Patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study.Dually diagnosed patients' responses to substance use disorder treatment.The influence of legal coercion on dropout from substance abuse treatment: results from a national survey.Professionals' perception on the management of patients with dual disorders.Developing and testing adaptive treatment strategies using substance-induced psychosis as an example.Living with acquired brain injury: self-concept as mediating variable in the adjustment process.A descriptive study of treatment provision for problem alcohol drinking in adult males in Khayelitsha, Cape Town, South Africa.A call for creativity in dual diagnosis research.Comorbid Psychopathology, Substance Use, and Treatment Outcomes: A Follow-Up of Inpatient Substance Users in Cape Town, South Africa Adapting the Integrated Dual-Disorder Treatment Model for Addiction Services

P2860

Q24596063-09652314-D19F-4050-B774-5E9E03645AD0 Q30367085-9691E25A-9D78-4A32-9515-CD543F023C36 Q34792192-E572D8BC-DB6F-46E0-B5D0-E67E5B72423F Q35796550-A9B6FE0E-F94F-4A5E-9A02-ECAEAEC8A306 Q36492527-0A21729D-3A51-4819-8BC4-7267655ECEA4 Q37279671-D06590F2-6F6C-4699-8F01-337EE0119E59 Q42119948-4DC886A9-29E9-45D1-8B8D-EA0282EB2C46 Q44906532-31C12713-F1CD-48E9-8EFA-0C967526AC8D Q47345189-5E0A7B60-AD9D-4141-A01F-E095CAF3EA45 Q50437935-B06797A2-D10F-4538-ACD7-2261C8336AC5 Q58214416-20C386CA-9AC9-40C9-85AB-AD9793439B58 Q58283080-9A6E3B87-394F-4CE5-90F0-5A190AD67A38

P2860

Enhancing validity in co-occurring disorders treatment research.

http://www.wikidata.org/entity/Q36540048

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Enhancing validity in co-occurring disorders treatment research.

@ast

Enhancing validity in co-occurring disorders treatment research.

@en

type

label

Enhancing validity in co-occurring disorders treatment research.

@ast

Enhancing validity in co-occurring disorders treatment research.

@en

prefLabel

Enhancing validity in co-occurring disorders treatment research.

@ast

Enhancing validity in co-occurring disorders treatment research.

@en

P1433

Q36540048-BC43503B-B4D1-48D2-93BF-A55D7D9E1694

P1476

Q36540048-EC87F3BD-F393-4099-8B74-616DED2A3452

P2093

Q36540048-164F6F6A-A329-4321-A762-39DC1DBDCF16

Q36540048-2A2FDC11-10A0-4309-A0EE-8396142A923D

Q36540048-C34C4C6D-4331-4DA6-84B3-04C3D61C3BD4

Q36540048-E577D979-97C7-4E63-8455-96FC6548725E

Q36540048-E7A1A97E-12E3-4667-9763-F0CDA2A6DBCA

P2860

Q36540048-168F6D01-A2EC-4D32-942C-0E3750783EBE

Q36540048-1D1D5CE8-A435-4D14-B253-2B6A4A99A3FD

Q36540048-2191B3D6-4565-4079-B8FC-EF67DACFBD9C

Q36540048-23B43F53-26B8-4D5F-85F2-0B7B9FE42721

Q36540048-25F7D806-1E65-416E-9B09-F17724B26E5C

Q36540048-2E544323-FC57-4B73-87B8-FC8287B07E6F

Q36540048-3A934C71-27ED-419F-A848-97C4FBC3EC51

Q36540048-44DA3156-AA93-451F-B9EE-E09CF208C346

Q36540048-4731C8BE-8207-4619-9EA8-64803B4E3E5F

Q36540048-5655C260-8D79-46FF-9C36-66099F9B196D

P304

Q36540048-5ED60F1E-48AF-4B40-9043-DF8D357E6217

P31

Q36540048-51B5A199-94E3-4C05-9203-8C4C107A7A5F

P356

Q36540048-747A2DBF-2890-4111-90A0-B677E117526B

P407

Q36540048-38875A89-07CE-4621-AB44-532A21A7CC1A

P433

Q36540048-1CC2D443-3B9F-46B1-8DD2-6AA9E1817D34

P478

Q36540048-064390A6-2409-4362-B268-A59A1C37B4F6

P50

Q36540048-25651592-EAB6-4743-920F-3324B5C5A9EF

P577

Q36540048-FBD7A73B-D8C6-4C2D-AAAA-FE21C7E6F344

P5875

Q36540048-66DCE745-9CE5-480D-89DC-37C0B3373B21

P698

Q36540048-6EF98821-ADDE-424A-B683-84B2B3E1D13E

P932

Q36540048-877914D2-26ED-48FD-A9D4-CAA13D43062A

P356

P1433

Schizophrenia Bulletin

P1476

Enhancing validity in co-occurring disorders treatment research.

@en

P2093

Alan I Green

http://www.w3.org/2001/XMLSchema#string

Gregory J McHugo

http://www.w3.org/2001/XMLSchema#string

Haiyi Xie

http://www.w3.org/2001/XMLSchema#string

Mary F Brunette

http://www.w3.org/2001/XMLSchema#string

Susan M Essock

http://www.w3.org/2001/XMLSchema#string

P2860

Determinants of medication compliance in schizophrenia: empirical and clinical findings

A comparison of methods to test mediation and other intervening variable effects

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

Using behavioral reinforcement to improve methadone treatment participation

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.

Strengthening clinical effectiveness trials: equipoise-stratified randomization.

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.

An experimental design for the development of adaptive treatment strategies.

Mediators and moderators of treatment effects in randomized clinical trials.

Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment

P304

655-665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/SCHBUL/SBL009

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Robert E. Drake

P577

2006-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6937230

http://www.w3.org/2001/XMLSchema#string

P698

16849398

http://www.w3.org/2001/XMLSchema#string

P932

2632278

http://www.w3.org/2001/XMLSchema#string